You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 20, 2025

Drug Price Trends for DOLISHALE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for DOLISHALE

Average Pharmacy Cost for DOLISHALE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
DOLISHALE 90-20 MCG TABLET 50742-0659-84 1.11861 EACH 2025-03-19
DOLISHALE 90-20 MCG TABLET 50742-0659-28 1.11861 EACH 2025-03-19
DOLISHALE 90-20 MCG TABLET 50742-0659-84 1.02210 EACH 2025-02-19
DOLISHALE 90-20 MCG TABLET 50742-0659-28 1.02210 EACH 2025-02-19
DOLISHALE 90-20 MCG TABLET 50742-0659-84 0.90766 EACH 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Dolishale

Overview of Dolishale

Dolishale, a combined oral contraceptive (COC), contains 90 mcg of levonorgestrel and 20 mcg of ethinyl estradiol. It is indicated for the prevention of pregnancy in women who choose oral contraceptives as their method of contraception[1].

Market Context

The global market for contraceptives, including oral contraceptives like Dolishale, is part of a broader pharmaceutical landscape that is experiencing significant growth. Here are some key points to consider:

Global Contraceptive Market

The demand for effective and reliable contraceptive methods continues to drive the market. The global contraceptive market is expected to grow, influenced by factors such as increasing awareness about family planning, government initiatives to promote contraception, and advancements in contraceptive technologies[4].

Drug Delivery Systems Market

The broader drug delivery systems market, which includes various forms of contraceptive delivery, is projected to expand significantly. By 2035, this market is expected to reach a revenue of USD 433 billion, up from approximately USD 42 billion in 2022. This growth is driven by the increasing need for effective drug delivery systems, including those for contraceptives[4].

Pricing and Cost Analysis

Current Pricing

As of the current data, the cost for Dolishale (20 mcg-90 mcg) oral tablets is around $27 for a supply of 28 tablets, depending on the pharmacy. This price is for cash-paying customers and does not include insurance plans. A generic version of Dolishale is also available, with prices starting from $62.95 for 84 tablets[2].

Price Projections

Given the competitive nature of the pharmaceutical market and the availability of generic versions, prices for Dolishale and similar contraceptives may remain relatively stable or see modest increases. Here are some factors that could influence price projections:

  • Generic Competition: The presence of generic versions can keep prices competitive. As more generics enter the market, prices may decrease or stabilize.
  • Market Demand: Increasing demand for effective contraceptives could lead to higher prices if supply does not keep pace.
  • Regulatory Factors: Changes in healthcare policies or regulations could impact pricing. For example, increased coverage under insurance plans could reduce out-of-pocket costs for consumers.
  • Technological Advancements: New technologies in drug delivery systems might introduce more expensive but more effective options, potentially affecting the pricing of traditional oral contraceptives like Dolishale[4].

Market Segmentation and Target Audience

Demographics

The primary target audience for Dolishale is women of reproductive age who are seeking effective contraception. This demographic includes a wide range of women, from those in their teens to those in their 40s.

Geographic Market

The market for Dolishale is global, but it is particularly significant in regions with high population growth and where family planning is a priority. North America and Europe are key markets due to their well-established healthcare systems and high demand for contraceptive services[4].

Competitive Landscape

Dolishale operates in a highly competitive market with numerous other oral contraceptives available. Key competitors include other combined oral contraceptives that contain different combinations of estrogen and progestin. The market is also influenced by other forms of contraception, such as intrauterine devices (IUDs) and injectable contraceptives[5].

Consumer Preferences and Trends

Convenience and Efficacy

Consumers are increasingly looking for convenient and highly effective contraceptive methods. Dolishale, with its simple daily regimen and high efficacy rate, aligns well with these preferences. However, trends towards more long-term solutions like IUDs and implants may also impact the market for oral contraceptives[1].

Cost and Accessibility

Cost is a significant factor for many consumers. The availability of generic versions and discount programs can make Dolishale more accessible to a broader audience. Programs like the Drugs.com Discount Card, which can save up to 80% on prescription medicines, are particularly beneficial[2].

Regulatory and Safety Considerations

Contraindications and Warnings

Dolishale, like other hormonal contraceptives, comes with certain contraindications and warnings, such as an increased risk of thromboembolism. These factors can influence market perception and usage rates. Healthcare providers must carefully consider these risks when prescribing Dolishale[1].

Post-Market Surveillance

Continuous monitoring of adverse effects and safety data is crucial for maintaining market confidence. Regulatory bodies and pharmaceutical companies must ensure that post-market surveillance is robust to identify any potential issues early[3].

Key Takeaways

  • Market Growth: The global contraceptive market is expected to grow, driven by increasing demand and advancements in technology.
  • Pricing: Current prices for Dolishale are around $27 for a 28-tablet supply, with generic options available. Prices may remain stable or see modest increases.
  • Competitive Landscape: Dolishale competes with other oral contraceptives and forms of contraception, necessitating a focus on convenience, efficacy, and cost.
  • Consumer Preferences: Consumers prioritize convenience, efficacy, and affordability, influencing the market dynamics.
  • Regulatory Considerations: Safety and regulatory compliance are critical for maintaining market presence.

FAQs

  1. What is Dolishale used for? Dolishale is used for the prevention of pregnancy in women who choose oral contraceptives as their method of contraception[1].

  2. How much does Dolishale cost? The cost for Dolishale is around $27 for a supply of 28 tablets, depending on the pharmacy. Generic versions are also available starting from $62.95 for 84 tablets[2].

  3. What are the key ingredients in Dolishale? Dolishale contains 90 mcg of levonorgestrel and 20 mcg of ethinyl estradiol[1].

  4. Can Dolishale be used immediately after childbirth or abortion? Dolishale may be initiated no earlier than day 28 postpartum in nonlactating mothers or after a second-trimester abortion due to the increased risk of thromboembolism[1].

  5. Are there any contraindications for using Dolishale? Yes, Dolishale has contraindications, including an increased risk of thromboembolism. It should not be used in certain conditions, and healthcare providers must carefully consider these risks when prescribing[1].

Sources

  1. RxList: Dolishale (Levonorgestrel and Ethinyl Estradiol) - RxList
  2. Drugs.com: Dolishale Prices, Coupons, Copay Cards & Patient Assistance
  3. DrugBank: Ethinylestradiol: Uses, Interactions, Mechanism of Action - DrugBank
  4. GlobeNewswire: Drug Delivery Systems Market revenue to exceed USD 433 Billion by 2035
  5. DrugBank: Levonorgestrel: Uses, Interactions, Mechanism of Action - DrugBank

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.